Research and Markets: Global Benign Prostatic Hyperplasia Pipeline Highlights - 2014 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bk7ktm/global_benign) has announced the addition of the "Global Benign Prostatic Hyperplasia Pipeline Highlights - 2014" report to their offering.

The latest report "Global Benign Prostatic Hyperplasia Pipeline Highlights - 2014" provides most up-to-date information on key pipeline molecules in the global benign prostatic hyperplasia market. It covers emerging therapies for benign prostatic hyperplasia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides benign prostatic hyperplasia pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides benign prostatic hyperplasia pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides benign prostatic hyperplasia pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which benign prostatic hyperplasia pipeline products will be launched in the US and Ex-US till 2017.

Summary:

- Benign Prostatic Hyperplasia phase 3 clinical trial pipeline molecules

- Benign Prostatic Hyperplasia phase 2 clinical trial pipeline molecules

- Benign Prostatic Hyperplasia phase 1 clinical trial pipeline molecules

- Benign Prostatic Hyperplasia preclinical research pipeline molecules

- Benign Prostatic Hyperplasia discovery stage pipeline molecules

- Benign Prostatic Hyperplasia pipeline molecules short-term launch highlights

Key Topics Covered:

1. Benign Prostatic Hyperplasia Pipeline by Stages

2. Benign Prostatic Hyperplasia Pipeline by Drug Class

3. Benign Prostatic Hyperplasia Pipeline by Company

4. Benign Prostatic Hyperplasia Phase 3 Clinical Trial Insights

5. Benign Prostatic Hyperplasia Phase 2 Clinical Trial Insights

6. Benign Prostatic Hyperplasia Phase 1 Clinical Trial Insights

7. Benign Prostatic Hyperplasia Preclinical Research Insights

8. Benign Prostatic Hyperplasia Discovery Stage Insights

9. Appendix

10. Research Methodology

Tables

Figures

For more information visit http://www.researchandmarkets.com/research/bk7ktm/global_benign

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals